Cargando…
Combining Intravenous Thrombolysis and Antithrombotic Agents in Stroke: An Update
Autores principales: | Derex, Laurent, Paris, Chloé, Nighoghossian, Norbert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5850163/ https://www.ncbi.nlm.nih.gov/pubmed/29331961 http://dx.doi.org/10.1161/JAHA.117.007454 |
Ejemplares similares
-
Platelet Function Tests: Why They Fail to Guide Personalized Antithrombotic Medication
por: Gorog, Diana A, et al.
Publicado: (2015) -
Coronavirus Disease 2019–Associated Thrombosis and Coagulopathy: Review of the Pathophysiological Characteristics and Implications for Antithrombotic Management
por: Ortega‐Paz, Luis, et al.
Publicado: (2021) -
An Updated Review of Target‐Specific Oral Anticoagulants Used in Stroke Prevention in Atrial Fibrillation, Venous Thromboembolic Disease, and Acute Coronary Syndromes
por: Cove, Christina L., et al.
Publicado: (2013) -
Updates in Cardiac Amyloidosis: A Review
por: Banypersad, Sanjay M., et al.
Publicado: (2012) -
Pregnancy Complicated by Valvular Heart Disease: An Update
por: Nanna, Michael, et al.
Publicado: (2014)